Vital Art

Vital Art and Science (VAS) is a digital health company specializing in the development of mobile diagnostic tools for ophthalmology. The company's flagship product, myVisionTrack, is an FDA-cleared mobile application designed for the self-monitoring of patients with maculopathy, such as age-related macular degeneration and diabetic retinopathy. By utilizing a proprietary shape discrimination hyperacuity (SDH) test, the platform allows patients to track vision changes between office visits, enabling early detection of disease progression. VAS has established a significant partnership with Genentech to integrate this technology into clinical practice and trials.